NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
12.51
+0.12 (0.97%)
At close: Mar 9, 2026, 4:00 PM EDT
12.51
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT
NextCure Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
43
Market Cap
44.54M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veru Inc. | 16.89M |
| Palatin Technologies | 8.96M |
| Apollomics | 6.93M |
| Lipocine | 4.32M |
| Aligos Therapeutics | 2.19M |
NXTC News
- 4 days ago - NextCure Provides Business Update and Reports Full Year 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - NextCure Provides Business Update - GlobeNewsWire
- 3 months ago - NextCure to Present at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 4 months ago - NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts - GlobeNewsWire
- 4 months ago - NextCure Announces $21.5 Million Private Placement of Common Stock Priced at the Market Under Nasdaq Rules - GlobeNewsWire
- 4 months ago - NextCure Provides Business Update and Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 5 months ago - NextCure and Simcere Zaiming Announce Expansion of Ongoing Phase 1 Trial of SIM0505 (CDH6 ADC) into the United States - GlobeNewsWire
- 6 months ago - NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire